RadNet, Inc. (RDNT)

RadNet, Inc. is trading at $73.49, down 0.22% on the session. The 50 day average sits at $72.56 and the 200 day at $65.14, which puts the stock in a uptrend. RSI is at 57.9, which reads as strong, and MACD is bullish crossover. Volume is above average.

The nearest support is around $70.08 with resistance near $76.97, so that band frames the current range. Average daily movement is roughly $2.35, or about 3.2% of the share price, which is what any stop placement has to allow for. The overall health score of 77 out of 100 combines a trend score of 81, momentum of 83 and a risk score of 63.

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretations of breast, lung, and prostate images, as well as solutions for prostate cancer screening. In addition, it develops and delivers AI-powered health informatics solutions to drive quality, efficiency, and outcomes in imaging and radiology; informatics designed for outpatient radiology; and DeepHealth OS, a cloud-native operating system that helps in the operations of the radiology service. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.